Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Goodwill (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Goodwill readings, the most recent being $14.9 million for Q4 2021.

  • On a quarterly basis, Goodwill changed 0.0% to $14.9 million in Q4 2021 year-over-year; TTM through Dec 2021 was $14.9 million, a 0.0% change, with the full-year FY2021 number at $14.9 million, changed 0.0% from a year prior.
  • Goodwill hit $14.9 million in Q4 2021 for Minerva Neurosciences, roughly flat from $14.9 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $14.9 million in Q4 2019 to a low of $14.9 million in Q4 2019.
  • Median Goodwill over the past 3 years was $14.9 million (2019), compared with a mean of $14.9 million.
  • The widest YoY moves for Goodwill: up 0.0% in 2020, down 0.0% in 2020.
  • Minerva Neurosciences' Goodwill stood at $14.9 million in 2019, then changed by 0.0% to $14.9 million in 2020, then changed by 0.0% to $14.9 million in 2021.
  • The last three reported values for Goodwill were $14.9 million (Q4 2021), $14.9 million (Q3 2021), and $14.9 million (Q2 2021) per Business Quant data.